These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30794827)

  • 1. Reductively cleavable polymer-drug conjugates based on dendritic polyglycerol sulfate and monomethyl auristatin E as anticancer drugs.
    Rades N; Achazi K; Qiu M; Deng C; Haag R; Zhong Z; Licha K
    J Control Release; 2019 Apr; 300():13-21. PubMed ID: 30794827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic polyglycerol sulfate as a novel platform for paclitaxel delivery: pitfalls of ester linkage.
    Sousa-Herves A; Würfel P; Wegner N; Khandare J; Licha K; Haag R; Welker P; Calderón M
    Nanoscale; 2015 Mar; 7(9):3923-32. PubMed ID: 25516353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperbranched Polyglycerol Loaded with (Zinc-)Porphyrins: Photosensitizer Release Under Reductive and Acidic Conditions for Improved Photodynamic Therapy.
    Staegemann MH; Gräfe S; Gitter B; Achazi K; Quaas E; Haag R; Wiehe A
    Biomacromolecules; 2018 Jan; 19(1):222-238. PubMed ID: 29232113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol.
    Calderón M; Graeser R; Kratz F; Haag R
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3725-8. PubMed ID: 19553109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
    Temming K; Meyer DL; Zabinski R; Dijkers EC; Poelstra K; Molema G; Kok RJ
    Bioconjug Chem; 2006; 17(6):1385-94. PubMed ID: 17105215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell.
    Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F
    J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of radio and dye labeled amino functionalized dendritic polyglycerol sulfates as multivalent anti-inflammatory compounds.
    Gröger D; Paulus F; Licha K; Welker P; Weinhart M; Holzhausen C; Mundhenk L; Gruber AD; Abram U; Haag R
    Bioconjug Chem; 2013 Sep; 24(9):1507-14. PubMed ID: 23924212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective deactivation of A549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel.
    Li B; Zhang XX; Huang HY; Chen LQ; Cui JH; Liu Y; Jin H; Lee BJ; Cao QR
    Int J Pharm; 2018 May; 543(1-2):8-20. PubMed ID: 29535039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modular approach for theranostic polymer conjugates with activatable fluorescence: Impact of linker design on the stimuli-induced release of doxorubicin.
    Nagel G; Tschiche HR; Wedepohl S; Calderón M
    J Control Release; 2018 Sep; 285():200-211. PubMed ID: 30005907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2-targeted antibody drug conjugates for ovarian cancer therapy.
    Jiang J; Dong L; Wang L; Wang L; Zhang J; Chen F; Zhang X; Huang M; Li S; Ma W; Xu Q; Huang C; Fang J; Wang C
    Eur J Pharm Sci; 2016 Oct; 93():274-86. PubMed ID: 27509865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.
    Ferber S; Tiram G; Sousa-Herves A; Eldar-Boock A; Krivitsky A; Scomparin A; Yeini E; Ofek P; Ben-Shushan D; Vossen LI; Licha K; Grossman R; Ram Z; Henkin J; Ruppin E; Auslander N; Haag R; Calderón M; Satchi-Fainaro R
    Elife; 2017 Oct; 6():. PubMed ID: 28976305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual intra- and extracellular release of monomethyl auristatin E from a neutrophil elastase-sensitive antibody-drug conjugate.
    Mohamed Amar IA; Huvelle S; Douez E; Letast S; Henrion S; Viaud-Massuard MC; Aubrey N; Allard-Vannier E; Joubert N; Denevault-Sabourin C
    Eur J Med Chem; 2022 Feb; 229():114063. PubMed ID: 34974337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound.
    Pes L; Koester SD; Magnusson JP; Chercheja S; Medda F; Abu Ajaj K; Rognan D; Daum S; Nollmann FI; Garcia Fernandez J; Perez Galan P; Walter HK; Warnecke A; Kratz F
    J Control Release; 2019 Feb; 296():81-92. PubMed ID: 30639692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel conjugation of tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL) with monomethyl auristatin E for efficient antitumor drug delivery.
    Pan LQ; Wang HB; Xie ZM; Li ZH; Tang XJ; Xu YC; Zhang C; Naranmandura H; Chen SQ
    Adv Mater; 2013 Sep; 25(34):4718-22. PubMed ID: 23847045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporter nanoparticle that monitors its anticancer efficacy in real time.
    Kulkarni A; Rao P; Natarajan S; Goldman A; Sabbisetti VS; Khater Y; Korimerla N; Chandrasekar V; Mashelkar RA; Sengupta S
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):E2104-13. PubMed ID: 27036008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E.
    Wang Y; Zhang X; Fan J; Chen W; Luan J; Nan Y; Wang S; Chen Q; Zhang Y; Wu Y; Ju D
    Front Immunol; 2018; 9():1799. PubMed ID: 30123222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates.
    Sutherland MS; Sanderson RJ; Gordon KA; Andreyka J; Cerveny CG; Yu C; Lewis TS; Meyer DL; Zabinski RF; Doronina SO; Senter PD; Law CL; Wahl AF
    J Biol Chem; 2006 Apr; 281(15):10540-7. PubMed ID: 16484228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.
    Lütje S; Gerrits D; Molkenboer-Kuenen JD; Herrmann K; Fracasso G; Colombatti M; Boerman OC; Heskamp S
    J Nucl Med; 2018 Mar; 59(3):494-501. PubMed ID: 29146698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evaluation of Bombesin-MMAE conjugates for targeted tumour therapy.
    Gomena J; Modena D; Cordella P; Vári B; Ranđelović I; Borbély A; Bottani M; Vári-Mező D; Halmos G; Juhász É; Steinkühler C; Tóvári J; Mező G
    Eur J Med Chem; 2024 Nov; 277():116767. PubMed ID: 39146832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.